Abstract
In autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus (SLE), autoantibodies are generated against a variety of macromolecules. Myositis is a human autoimmune disease characterized by weakness and wasting of muscle1. In American studies2,3, antibodies directed against soluble cellular constituents were detected by immunodiffusion in about 60% of cases; the commonest of these, found in 25% of patients, was antibody to the Jo-1 antigen. An antibody system referred to as PL-1 was recognized at a similar frequency in a series of patients studied at Hammersmith Hospital, London4. We show here that this system is identical with the Jo-1 system and demonstrate that the antigen is a polypeptide of molecular weight (Mr) 50,000. The protein is immunoprecipitated with tRNAHis and appears to be histidyl-tRNA synthetase. The identity of the Jo-1 antigen, the first of the RNA-associated antigens familiar in autoimmune disease5,6 to be characterized as a specific enzyme, suggests a model for virus involvement in autoantibody generation.
Similar content being viewed by others
References
Bohan, A. & Peter, J. B. New Engl. J. Med. 292, 344–347, 403–407 (1975).
Nishikai, M. & Reichlin, M. Arthr. Rheum. 23, 881–888 (1980).
Arnett, F. C., Hirsch, T. J., Bias, W. B., Nishikai, M. & Reichlin, M. J. Rheum. 8, 925–930 (1981).
Bernstein, R. M., Bunn, C. C., Hughes, G. R. V., Francoeur, A. M. & Mathews, M. B. (in preparation).
Tan, E. M. Adv. Immun. 33, 167–240 (1982).
Hardin, J. A. et al. J. clin. Invest. 70, 141–147 (1982).
Francoeur, A. M. & Mathews, M. B. Proc. natn. Acad. Sci. U.S.A. 79, 6772–6776 (1982).
Rosa, M. D., Hendrick, J. P., Lerner, M. R., Steitz, J. A. & Reichlin, M. Nucleic Acids Res. 11, 853–870 (1983).
Altwegg, M. & Kubli, E. Nucleic Acids Res. 8, 3259–3262 (1980).
Boisnard, M. & Petrissant, G. FEBS Lett. 129, 180–184 (1981).
Kane, S. M., Vugrincic, C., Finbloom, D. S. & Smith, D. W. E. Biochemistry 17, 1509–1514 (1978).
Currie, S. Acta neuropath. 15, 11–19 (1970).
Cambridge, G. & Stern, C. M. M. Clin. exp. Immun. 43, 211–219 (1981).
Whitaker, J. N. & Engel, W. K. New Engl. J. Med. 286, 333–338 (1972).
Stollar, B. D. & Ward, M. J. biol. Chem. 245, 1261–1266 (1970).
Chou, S. Archs Path. 86, 649–658 (1968).
Tobin, J. O'H. Br. med. Bull. 9, 201–205 (1953).
Travers, R. L., Hughes, G. R. V., Cambridge, G. & Sewell, J. R. Lancet 1, 1268 (1977).
Lindley, I. J. D. & Stebbing, N. J. gen. Virol. 34, 177–182 (1977).
Salomon, R. & Littauer, U. Z. Nature 249, 32–34 (1974).
Lerner, M. R., Boyle, J. A., Hardin, J. A. & Steitz, J. A. Science 211, 400–402 (1981).
Lerner, M. R., Andrews, N. C., Miller, G. & Steitz, J. A. Proc. natn. Acad. Sci. U.S.A. 78, 805–809 (1981).
Mathews, M. B. & Korner, A. Eur. J. Biochem. 17, 328–338 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mathews, M., Bernstein, R. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 304, 177–179 (1983). https://doi.org/10.1038/304177a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/304177a0
- Springer Nature Limited
This article is cited by
-
Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses
Cellular & Molecular Immunology (2021)
-
Evolutionary gain of highly divergent tRNA specificities by two isoforms of human histidyl-tRNA synthetase
Cellular and Molecular Life Sciences (2017)
-
Gli autoanticorpi nelle sindromi overlap reumatiche autoimmuni
La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine (2014)
-
Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
Arthritis Research & Therapy (2012)
-
Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment
Current Rheumatology Reports (2012)